Acinar-to-ductal metaplasia |
Mice |
Overexpressed |
HNF6 induces Sox9 expression, which is characteristic of ADM in humans |
[34, 35] |
|
Acinar-to-ductal metaplasia |
Mice |
Overexpressed |
Aberrant expression of p27 induces the nuclear expression of Sox9 |
[36] |
|
Mucinous cystic neoplasias, intraductal papillary mucinous neoplasias, pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinoma |
Mice |
Overexpressed |
SOX9 and Kras co-expression is associated with PDAC initiation |
[37] |
|
Pancreatic ductal adenocarcinoma |
88 tumors samples of PDAC |
Overexpressed |
Sox9 and p-Akt double-positive expression is related with an unfavorable prognosis, high TNM and distant metastasis |
[38] |
|
Pancreatic ductal adenocarcinoma |
Patient-derived tumor organoids with PDAC |
Overexpressed in cytoplasm |
High expression of Sox9 in cytoplasm is related with a poor DFS, OS, higher tumor grade and worse disease-specific survival compared to patients with nuclear Sox9 expression |
[39] |
|
Pancreatic cancer |
PANC1 and HPAC cell lines of pancreatic cancer |
Overexpressed |
Sox9 is highly expressed in pancreatic CSCs. Moreover, NF-κB subunit p65 positively regulates SOX9 |
[40] |
|
Pancreatic ductal adenocarcinoma |
HD3 colon cancer cells |
Overexpressed |
ST6Gal-I induces expression of Sox9, promoting stem-like cell properties |
[41] |
|
Pancreatic cancer |
PANC-1, Capan-1, BxPC-3, MiaPaCa-2 cell lines of pancreatic cancer |
Expression depending on chemoresistance |
High level of Sox9 is related to stronger chemoresistance to Gemcitabine |
[42] |
|
Pancreatic ductal adenocarcinoma |
HPDE cell line of PDAC |
Overexpressed |
GLI1 induces the transcription of Sox9 promoting stem cell properties |
[43] |
|
Pancreatic cancer |
PANC1 cell line of pancreatic cancer |
Downregulated |
Induction of EMT with TGF-β results in low levels of SOX9, FOXA2, and GATA4 |
[44] |
|
Pancreatic cancer |
Mice |
Overexpressed |
p53-/- mice enhanced sphere formation, increased expression of the stemness regulator Bmi1 and Klf4, and pancreatic multipotent progenitor markers as Ptf1a, Pdx1, Cpa1, c-myc, Hnf1b and Sox9 |
[45] |
|
Pancreatic cancer |
FG and L3.6pl cell lines of pancreatic cancer under hypoxia |
Overexpressed |
Under hypoxia conditions, FG cell line expresses high levels of Sox9 and L3.6pl. Besides, WNT, CXCR4, retinoic acid, and FAK signaling pathways are regulated by Sox9 in L3.6pI |
[46] |
|
Pancreatic ductal adenocarcinoma and anaplastic pancreatic cancer |
6 APC patients and 53 PDAC patients |
Overexpressed |
PDAC and APC have high expression of Sox9, being the expression of proteins related with CSCs and EMT process higher in APC samples than PDAC |
[30] |
|
Intraductal papillary mucinous neoplasm |
19 IPMN cases |
Overexpressed |
SOX9-positive cells were confined to the lower portions of the papillary structures of IPMN |
[47] |
|
Solid pseudopapillary tumor |
8 samples of SPT |
Overexpressed |
PDX1 and Sox9 are both expressed in the cytoplasm of SPT cell |
[48] |